DAR Earnings

DAR reported its FY2025Q3 earnings on 2025-10-23, showcasing a revenue of 1.56B against an estimate of 1.50B, resulting in a 4.13% surprise. The EPS was 0.12, surpassing the expected 0.13 by -7.69%. The stock experienced a 11.41% price change on the earnings day and a 8.64% change over the next five days, reflecting market reactions to the results.

Following DAR's FY2025Q3 earnings announcement on 2025-10-23, the stock price moved by 11.41% on the day of the release. Over the subsequent five days, it saw a 8.64% change. Historically, DAR's stock price tends to shift by an average of -2.39% in the 10 days leading up to earnings and -1.64% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate DAR's annual revenue to reach 1.51B, while the EPS is projected at 0.52. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between DAR's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, DAR's stock price typically moves by -2.39% in the 10 days before its earnings and -1.64% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.52 and revenue of 1.51B.

The earnings call summary shows a positive outlook with strong demand for the collagen and gelatin business, promising developments in the Nextida product line, and expected higher margins from biofuels. The Q&A section supports this with strategic moves like the Brazil acquisition and a focus on core capabilities. Despite some management vagueness, the overall sentiment is positive with potential growth in EBITDA and international markets. These factors suggest a positive stock price movement.